Vident Investment Advisory’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,303
| Closed | -$498K | – | 1088 |
|
|
2023
Q2 | $498K | Sell |
1,303
-453
| -26% | -$173K | 0.02% | 699 |
|
|
2023
Q1 | $608K | Buy |
1,756
+351
| +25% | +$122K | 0.02% | 702 |
|
|
2022
Q4 | $331K | Buy |
+1,405
| New | +$331K | 0.01% | 853 |
|
|
2022
Q3 | – | Sell |
-883
| Closed | -$271K | – | 1349 |
|
|
2022
Q2 | $271K | Sell |
883
-1,055
| -54% | -$324K | 0.01% | 1051 |
|
|
2022
Q1 | $795K | Sell |
1,938
-1,620
| -46% | -$665K | 0.02% | 785 |
|
|
2021
Q4 | $1.67M | Sell |
3,558
-416
| -10% | -$195K | 0.04% | 529 |
|
|
2021
Q3 | $1.69M | Sell |
3,974
-2,188
| -36% | -$929K | 0.05% | 507 |
|
|
2021
Q2 | $2.21M | Buy |
6,162
+2,231
| +57% | +$801K | 0.07% | 367 |
|
|
2021
Q1 | $1.11M | Buy |
3,931
+1,162
| +42% | +$327K | 0.04% | 586 |
|
|
2020
Q4 | $784K | Buy |
2,769
+40
| +1% | +$11.3K | 0.03% | 599 |
|
|
2020
Q3 | $750K | Sell |
2,729
-626
| -19% | -$172K | 0.04% | 569 |
|
|
2020
Q2 | $762K | Buy |
3,355
+430
| +15% | +$97.7K | 0.04% | 552 |
|
|
2020
Q1 | $445K | Buy |
+2,925
| New | +$445K | 0.03% | 599 |
|
|
2015
Q3 | – | Sell |
-11,194
| Closed | -$650K | – | 1160 |
|
|
2015
Q2 | $650K | Buy |
11,194
+411
| +4% | +$23.9K | 0.09% | 333 |
|
|
2015
Q1 | $649K | Sell |
10,783
-1,550
| -13% | -$93.3K | 0.13% | 243 |
|
|
2014
Q4 | $657K | Buy |
+12,333
| New | +$657K | 0.22% | 136 |
|